The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Automated therapy preparation of isoleucine formulations using 3D printing for the treatment of MSUD: First single-centre, prospective, crossover study in patients
Open accessAbstract
Maple syrup urine disease (MSUD) is a rare metabolic disorder with a worldwide prevalence of 1 in every 185,000 live births. However, certain populations display a significant overexpression of the disorder where incidence is reported to be 1 in every 52, 541 new-borns. The first-line therapy for MSUD involves a strict dietary leucine restriction and oral supplementation of isoleucine and valine. The dose administered to patients requires strict tailoring according to age, weight and blood levels. In current clinical practice, however, practitioners still have to prepare extemporaneous formulations due to the lack of suitable oral treatments for MSUD. Herein we evaluate for the first time the use of 3D printing in a hospital setting for the preparation of personalised therapies with the aim of improving safety and acceptability to isoleucine supplementation in paediatric patients suffering from MSUD. The study was a single-centre, prospective crossover experimental study. Four paediatric patients with MSUD (aged 3-16 years) were treated at the Clinic University Hospital in Santiago de Compostela, Spain which is a MSUD reference hospital in Europe. The primary investigation was to evaluate isoleucine blood levels after six months treatment with two types of formulations; conventional capsule prepared by manual compounding and personalised chewable formulations prepared by automated 3D printing. A secondary investigation was to evaluate patient acceptability of 3D printed formulations prepared with different flavours and colours. Isoleucine blood levels in the patients were well controlled using both types of formulations, however, the 3D printed therapy showed mean levels closer to the target value and with less variability (200 - 400µM). The 3D printed formulations were well accepted by the patients regarding flavour and colour. The study demonstrates for the first time that 3D printing offers a feasible, rapid and automated approach to prepare oral tailored-dose therapies in a hospital setting. 3D printing has shown to be an effective manufacturing technology in producing chewable isoleucine printlets as a treatment of MSUD with good acceptability.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new chapter in pharmaceutical manufacturing: 3D-printed drug products
Norman, J., Madurawe, R. D., Moore, C. M. V., Khan, M. A., & Khairuzzaman, A. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.03.001 · Cited by 810
Innovations in 3D printing: a 3D overview from optics to organs
Schubert, C., van Langeveld, M. C., & Donoso, L. A. (2014) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2013-304446 · Cited by 753
Bioresorbable Airway Splint Created with a Three-Dimensional Printer
Zopf, D. A., Hollister, S. J., Nelson, M. E., Ohye, R. G., & Green, G. E. (2013) · New England Journal of Medicine · doi:10.1056/nejmc1206319 · Cited by 589
Emergence of 3D Printed Dosage Forms: Opportunities and Challenges
Alhnan, M. A., Okwuosa, T. C., Sadia, M., Wan, K.-W., Ahmed, W., & Arafat, B. (2016) · Pharmaceutical Research · doi:10.1007/s11095-016-1933-1 · Cited by 554
3D Printing Pharmaceuticals: Drug Development to Frontline Care
Trenfield, S. J., Awad, A., Goyanes, A., Gaisford, S., & Basit, A. W. (2018) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2018.02.006 · Cited by 502
Self-citationDiagnosis and Treatment of Maple Syrup Disease: A Study of 36 Patients
Morton, D. H., Strauss, K. A., Robinson, D. L., Puffenberger, E. G., & Kelley, R. I. (2002) · Pediatrics · doi:10.1542/peds.109.6.999 · Cited by 326
3D printed medicines: A new branch of digital healthcare
Awad, A., Trenfield, S. J., Gaisford, S., & Basit, A. W. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.07.024 · Cited by 265
Self-citationReshaping drug development using 3D printing
Awad, A., Trenfield, S. J., Goyanes, A., Gaisford, S., & Basit, A. W. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.05.025 · Cited by 263
Self-citationPatient acceptability of 3D printed medicines
Goyanes, A., Scarpa, M., Kamlow, M., Gaisford, S., Basit, A. W., & Orlu, M. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.07.064 · Cited by 246
Self-citationDirect powder extrusion 3D printing: Fabrication of drug products using a novel single-step process
Goyanes, A., Allahham, N., Trenfield, S. J., Stoyanov, E., Gaisford, S., & Basit, A. W. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.118471 · Cited by 246
Self-citation
Cited by
3D Printing as a Promising Tool in Personalized Medicine
Vaz, V. M., & Kumar, L. (2021) · AAPS PharmSciTech · doi:10.1208/s12249-020-01905-8 · Cited by 409
Connected healthcare: Improving patient care using digital health technologies
Awad, A., Trenfield, S. J., Pollard, T. D., Ong, J. J., Elbadawi, M., McCoubrey, L. E., Goyanes, A., Gaisford, S., & Basit, A. W. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113958 · Cited by 405
Self-citation3D printing: Principles and pharmaceutical applications of selective laser sintering
Awad, A., Fina, F., Goyanes, A., Gaisford, S., & Basit, A. W. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119594 · Cited by 371
Self-citationSeoane-Viaño, I., Januskaite, P., Alvarez-Lorenzo, C., Basit, A. W., & Goyanes, A. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.02.027 · Cited by 357
Self-citationShaping the future: recent advances of 3D printing in drug delivery and healthcare
Trenfield, S. J., Awad, A., Madla, C. M., Hatton, G. B., Firth, J., Goyanes, A., Gaisford, S., & Basit, A. W. (2019) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2019.1660318 · Cited by 299
Self-citation
Metadata
- Authors
- Goyanes, A., Madla, C. M., Umerji, A., Duran Piñeiro, G., Giraldez Montero, J. M., Lamas Diaz, M. J., Gonzalez Barcia, M., Taherali, F., Sánchez-Pintos, P., Couce, M.-L., Gaisford, S., & Basit, A. W.
- Venue
- International Journal of Pharmaceutics
- Publisher
- Elsevier BV
- Published
- 2019-08
- Volume
- 567
- Pages
- 118497
- ISSN
- 0378-5173 (ISSN-L)
- OpenAlex
- W2954070504
- Cited by
- 292
- References
- 28
- FWCI
- 16.58
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Automated therapy preparation of isoleucine formulations using 3D printing for the treatment of MSUD: First single-centre, prospective, crossover study in patients. https://app.cochat.ai/papers/10.1016/j.ijpharm.2019.118497
- The paper
- Goyanes, A., Madla, C. M., Umerji, A., Duran Piñeiro, G., Giraldez Montero, J. M., Lamas Diaz, M. J., Gonzalez Barcia, M., Taherali, F., Sánchez-Pintos, P., Couce, M.-L., Gaisford, S., & Basit, A. W. (2019). Automated therapy preparation of isoleucine formulations using 3D printing for the treatment of MSUD: First single-centre, prospective, crossover study in patients. International Journal of Pharmaceutics. https://doi.org/10.1016/j.ijpharm.2019.118497
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.